0001689813-19-000130.txt : 20191220
0001689813-19-000130.hdr.sgml : 20191220
20191220214008
ACCESSION NUMBER: 0001689813-19-000130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191218
FILED AS OF DATE: 20191220
DATE AS OF CHANGE: 20191220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AGUIAR ERIC
CENTRAL INDEX KEY: 0001262325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 191303316
MAIL ADDRESS:
STREET 1: 888 7TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
wf-form4_157689598816947.xml
FORM 4
X0306
4
2019-12-18
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001262325
AGUIAR ERIC
C/O AISLING CAPITAL LLC
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Employee Stock Option (Right to Buy)
52.13
2019-12-18
4
A
0
12000
0
A
2029-12-18
Common Shares
12000.0
12000
I
By Spouse
The option became exercisable with respect to 3,000 of the shares underlying the option on the grant date (December 18, 2019), and the remaining 9,000 shares underlying the option vest in three equal installments on December 18, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer as of each applicable vesting date.
This stock option is held by the reporting person's spouse as an employee of the issuer.
/s/ Jim Engelhart, Attorney-in-fact
2019-12-20